Opinion
Tom Powles, MIBC
Tom Powles/X

Tom Powles: Opening a New Area for Cis-Ineligible MIBC

Tom Powles, Head of Solid Tumor Research at Barts Cancer Institute, shared a post on X:

“The +ve perioperative EVP trial for OS in cis ineligible MIBC may open a new area.

Especially if it’s like EVP in M1 disease. 3 more trials in this area are awaited, which test

  1. EVP vs cisplatin (NIAGARA population),
  2. EV/PD1/CTLA4 vs surgery
  3. treatment based on ctDNA status.”

Tom Powles: Opening a New Area for Cis-Ineligible MIBC

More posts featuring Tom Powles.

bladder cancer cancer MIBC muscle-invasive bladder cance OncoDaily Oncology Tom Powles